Work

Outcomes Using TORS or Definitive Chemoradiation for T3/T4 HPV+ Oropharynx Cancer

Year: 2021

Type: article

Study design: Observational Study

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2021.07.1159

Authors: E.J. Anstadt, R.M. Carey, D. Shimunov, A. Lin, A.R. Barsky, C.M. Wright, A. Doucette, S.D. Swisher-McClure, R. Cohen, J. Bauml, G.S. Weinstein, B. O'Malley, A. Chalian, C. Rassekh, K. Rajasekaran, D. Basu, S.B. Cannady, R. Brody, J. Newman, J.N. Lukens

Institutions: University of Pennsylvania, University of Maryland Medical Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3208104902

FWCI:

Cites:

Cited by:

Related to: 10